Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients

Blood Purification

Volumn 26, Issue 4, 2008, Pages 371-378

  Sakata, Tomoko ^a   Furuya, Ryuichi ^b   Shimazu, Takako ^a   Odamaki, Mari ^a   Ohkawa, Sakae ^a   Kumagai, Hiromichi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Iwata City Hospital   (Japan)

Author keywords

Advanced oxidation protein products; Coenzyme Q10; Hemodialysis; Oxidative stress; Oxygen radical absorbing capacity; Trolox equivalent antioxidant capacity

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; MALONALDEHYDE; OXYGEN RADICAL; UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE; UBIQUINONE;

ADULT; AGED; ANALYTIC METHOD; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG ACTIVITY; DRUG EFFECT; ENZYME BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY POLYCYSTIC DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHROSCLEROSIS; OXIDATIVE STRESS; OXYGEN RADICAL ABSORBING CAPACITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TROLOX EQUIVALENT ANTIOXIDANT CAPACITY;

AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RENAL DIALYSIS; UBIQUINONE;

EID: 48349147500     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135605     Document Type: Article

References (29)

1. Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP: Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 2005;9:37-46.
2. Ward RA, McLeish KR: Oxidant stress in hemodialysis patients: what are the determining factors? Artif Organs 2003;27:230-236.
3. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-1538.
4. Yang CC, Hsu SP, Wu MS, Hsu SM, Chien CT: Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysisinduced oxidative stress. Kidney Int 2006;69:706-714.
5. Stocker R, Bowry VW, Frei B: Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 1991;88:1646-1650.
6. Thomas SR, Neuzil J, Stocker R: Cosupplementation with coenzyme Q prevents the prooxidant effect of α-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Arterioscler Thromb Vasc Biol 1996;16:687-696.
7. Wang XL, Rainwater DL, Mahaney MC, Stocker R: Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons. Am J Clin Nutr 2004;80:649-655.
8. Niibori K, Wroblewski KP, Yokoyama H, Crestanello JA, Whitman GJ: Bioenergetic effect of liposomal coenzyme Q10 on myocardial ischemia reperfusion injury. Biofactors 1999;9:307-313.
9. Grieb P, Ryba MS, Sawicki J, Chrapusta SJ: Oral coenzyme Q10 administration prevents the development of ischemic brain lesions in a rabbit model of symptomatic vasospasm. Acta Neuropathol (Berl) 1997;94:363-368.
10. Ohkawa S, Yoneyama T, Shimoi K, Takita T, Maruyama Y, Kumagai H: Pro-oxidative effect of α-tocopherol in the oxidation of LDL isolated from co-antioxidant-depleted non-diabetic hemodialysis patients. Atherosclerosis 2004;176:411-418.
11. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313.
12. Templar J, Kon SP, Milligan TP, Newman DJ, Raftery MJ: Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. Nephrol Dial Transplant 1999;14:946-951.
13. Prior RL, Hoang H, Gu L, Wu X, Bacchiocca M, Howard L, Hampsch-Woodill M, Huang D, Ou B, Jacob R: Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity [ORAC(FL)]) of plasma and other biological and food samples. J Agric Food Chem 1993;51:3273-3279.
14. Erel O: A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-285.
15. Yamashita S, Yamamoto Y: Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Biochem 1997;250:66-73.
16. National Kidney Foundation Kidney Disease Outcomes Quality Initiative: Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000;35:S17-S104.
17. Yamamoto Y, Yamashita S: Redox status of plasma coenzyme Q as an indicator of oxidative stress; in Kagan VE, Quinn P J (eds): Coenzyme Q: Molecular Mechanisms in Health and Disease. Boca Raton, CRC Press, 2001, pp 261-268.
18. Capeillere-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V: Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 2004;1689:91-102.
19. Galli F: Protein damage and inflammation in uremia and dialysis patients. Nephrol Dial Transplant 2007;22(suppl 5):v20-v36.
20. Gomez-Diaz C, Villalba JM, Perez-Vicente R, Crane FL, Navas P: Ascorbate stabilization is stimulated in rho(0)HL-60 cells by CoQ10 increase at the plasma membrane. Biochem Biophys Res Commun 1997;234:79-81.
21. Ono K: Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients. Clin Nephrol 1986;26:239-243.
22. Prior RL, Cao G: In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 1999;27:1173-1181.
23. Nguyen-Khoa T, Massy ZA, Witko-Sarsat V, Thevenin M, Touam M, Lambrey G, Lacour B, Drueke TB, Descamps-Latscha B: Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Kidney Int 1999;56:747-753.
24. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS: Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995;41:1135-1138.
25. Sofic E, Rustembegovic A, Kroyer G, Cao G: Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathy. J Neural Transm 2002;109:711-719.
26. Samouilidou EC, Grapsa EJ, Kakavas I, Lagouranis A, Agrogiannis B: Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Int Urol Nephrol 2003;35:393-397.
27. Mircescu G, Capusa C, Stoian I, Vargolici B, Barbulescu C, Ursea N: Global assessment of serum antioxidant status in hemodialysis patients. J Nephrol 2005;18:599-605.
28. Cao G, Prior RL, Cutler RG, Yu BP: Effect of dietary restriction on serum antioxidant capacity in rats. Arch Gerontol Geriatr 1997;25:245-253.
29. Wang XL, Rainwater DL, Mahaney MC, Stocker R: Cosupplementation with vitamin E and coenzyme Q10 reduces circulating markers of inflammation in baboons. Am J Clin Nutr 2004;80:649-655.